Corbo, Christian .
HRN: 23-01-30 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/08/2023
05/14/2023
IV
25mg
Q8H
PCAP D
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes